RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 32 - per page Next page
Order by
SkyePharma PLC licenses European marketing and distribution rights for DepoCyte, a treatment for lymphomatous meningitis, to Mundipharma More
Morphochem names Alfred E. Seidel as CEO. Dr Seidel will drive strategic change at the Company as it advances its products into clinical development. More
On January 15th 2003, the European Patent Office has granted final patent protection (EP 1275377A1) to APR's proprietary technology for the preparation of granulates containing liposoluble substances. More
HELSINN AND ITALFARMACO SIGN A LICENSE AGREEMENT FOR PALONOSETRON (ONICIT) IN ITALY More
Dr David Rees becomes Director of Medicinal Chemistry at Astex More
G2M Cancer Drugs AG and Desitin Arzneimittel GmbH announced today that they have entered into an agreement to develop an innovative formulation for the histone deacetylase (HDAC) inhibitor G2M-777 for cancer treatment. More
Morphochem AG and Xenogen Corp. today announced that both companies have entered into a research collaboration to discover targets and develop compounds effective against bacterial biofilms. More
The American Skin Association will honor Braham Shroot, B.Sc., Ph.D., Chief Scientific Officer and Vice President of Research and Development for DFB Pharmaceuticals, Inc. with a Lifetime Achievement Award More
Astex technology announce exclusive research collaboration and licence agreement with the Institute of Cancer Research and Cancer Research Technology More
The American Skin Association (ASA) will honor Braham Shroot, B.Sc., Ph.D. with a Lifetime Achievement Award More
Displaying 1..10 of 32 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us